top of page
Patient on Scale

Medically Assisted Weight Loss

01

Initial Consult & Labs

02

Treatment Initiation 

03

Meal Guide

04

Weigh Ins & Follow Ups

Semaglutide

Semaglutide is a glucagon-like peptide-1 receptor (GLP-1) agonist, which helps your pancreas release insulin to decrease blood sugar levels which promotes weight loss. This is done by activating a blood-sugar regulating protein found within the beta cells of your pancreas. It delays stomach emptying leading to a feeling of fullness & satisfaction, and slows intestinal motility. Studies1 have shown that using a GLP-1 once weekly plus lifestyle intervention was associated with sustained, clinically relevant reduction in body weight.1 Participates are showing real results with an average of 12-15lbs loss per month!

In a GLP-1 weight loss trial2 that included almost 2000 adults with BMIs of 30 and greater, more than half of the participants lost 15% of their body weight. Most of the participants lost at least 10% of their body weight. The participants were not diabetic indicating GLP-1's are beneficial for weight loss in non-diabetic persons. Also, the participants taking GLP-1s showed improvements in blood pressure, blood sugar, and heart disease risk.

References:

1. https://www.fda.gov/news-events/press-announcements/fda-approves-new-drug-treatment-chronic-weight-management-first-2014

2. https://www.nejm.org/doi/full/10.1056/NEJMoa2032183

Tirzepatide

Tirzepatide is also a a glucagon-like peptide receptor antogonist which basically improves glycemic control in the pancreas. This unique medication mimics two hormones naturally found in the body: GLP-1 and GIP. Tirzepatide also delays gastric empyting which aids in suppressing your appetite.

Study's have shown more significant weight loss with Tirzepatide and milder side effects as compared to Semaglutide. Using tirzepatide resulted in a weight loss of 17.8% compared with 12.4% for semaglutide.

Vaccine

Monthly Program

  • Initial consultation with NP

  • Review labs & goals

  • Start weekly dose administration

  • Dietary plan

  • Weekly weigh-ins/follow-up

  • 15% off Slim Goodie or Goat Athlete IV drip

Semaglutide

$450.00/month

Tirzepatide 

Starts at $600/month
Kitchen Scale

Administration

  • Our MAWL program involves an once-weekly injectable prescription medication used for adults with a diagnosis of obesity (BMI >30) or overweight (BMI >27 with weight related chronic conditions), needing help losing weight and keeping it off. 

  • It is given subcutaneously in your abdomen once weekly via tiny needle (similar to insulin injection) 

  • First month, our NP will administer injections. If comfortable the following months you may self-administer at home. 

bottom of page